DeepMed Research

THE AFFILIATED HOSPITAL OF QINGDAO UNIVERSITY

🇨🇳China

Country: 🇨🇳China

Ownership: Private

Employees: -

Market Cap: -

Website: http://www.qduh.cn

Clinical Trials

The Effects of Colorectal Prehabilitation Via Reinfusion or Retention Enema of Ileal Contents Filtrate on the Defecation Functions for the LAR Patients With Ileostomy Before Stoma Closure

Not Applicable

Recruiting

Conditions: Low Anterior Resection Syndrome

Interventions: Behavioral: preoperative prehabilitation treatment of ileostomy contents filtrate reinfusion through distal ileocolon or retention of enema colon

First Posted Date: 2024-08-26

Last Posted Date: 2024-08-26

Lead Sponsor: The Affiliated Hospital of Qingdao University

Target Recruit Count: 154

Registration Number: NCT06569966

Locations: 🇨🇳
the Affiliated Hospital of Qingdao, Qingdao, Shandong, China

SCG142 TCR-T Cells for Human Papillomavirus-Associated Carcinomas

Phase 1

Recruiting

Conditions: Anal Cancer
HPV-Related Malignancy
Cervical Cancer
Vulva Cancer
Penile Cancer
Human Papillomavirus Associated Carcinomas
Head and Neck Cancers
Vaginal Cancer

Interventions: Biological: SCG142 TCR-T cells

First Posted Date: 2024-08-09

Last Posted Date: 2024-08-09

Lead Sponsor: The Affiliated Hospital of Qingdao University

Target Recruit Count: 18

Registration Number: NCT06544720

Locations: 🇨🇳
The affiliated hosptial of qingdao university, Qingdao, Shandong, China

Whole Course Multi-model Prehabilitation to Improve Clinical Outcome in Patients Undergoing Neoadjuvant Treatment Prior to Gastrectomy

Not Applicable

Recruiting

Conditions: Gastric Cancer
Prehabilitation

Interventions: Behavioral: ERAS program
Behavioral: Multimodal prehabilitation program

First Posted Date: 2024-07-26

Last Posted Date: 2024-07-26

Lead Sponsor: The Affiliated Hospital of Qingdao University

Target Recruit Count: 90

Registration Number: NCT06521541

Locations: 🇨🇳
Department of Gastrointestinal Surgery, Qingdao University Affiliated Hospital, Qingdao, Shandong, China

ERAS for Gastric Cancer Patients After NACT

Completed

Conditions: Gastric Cancer

Interventions: Other: enhanced recovery after surgery
Other: conventional perioperative management

First Posted Date: 2024-04-15

Last Posted Date: 2024-04-15

Lead Sponsor: The Affiliated Hospital of Qingdao University

Target Recruit Count: 252

Registration Number: NCT06365814

Locations: 🇨🇳
Department of Gastrointestinal Surgery, Qingdao University Affiliated Hospital, Qingdao, Shandong, China

Preoperative Neoadjuvant Immunotherapy Combined With Chemotherapy for Stage Ⅲ Unresectable Non-small Cell Lung Cancer

Phase 4

Recruiting

Conditions: Non-small-cell Lung Cancer (NSCLC)

Interventions: Drug: Tislelizumab
Drug: Pemetrexed (Non-squamous NSCLC) or Nab-paclitaxel(Squamous NSCLC)
Drug: Carboplatin or Cisplatin
Procedure: Surgery

First Posted Date: 2024-04-10

Last Posted Date: 2024-04-10

Lead Sponsor: The Affiliated Hospital of Qingdao University

Target Recruit Count: 30

Registration Number: NCT06357598

Locations: 🇨🇳
the Affiliated Hospital of Qingdao University, Qingdao, Shandong, China

Clinical Effects of Absorbable and Non-absorbable Suture in Bronchial Sleeve Resection

Not Applicable

Recruiting

Conditions: Suture, Complication

Interventions: Device: Non-absorbable Suture
Device: Absorbable Suture

First Posted Date: 2024-04-03

Last Posted Date: 2024-04-03

Lead Sponsor: The Affiliated Hospital of Qingdao University

Target Recruit Count: 40

Registration Number: NCT06344962

Locations: 🇨🇳
the Affiliated Hospital of Qingdao University, Qingdao, Shandong, China

A Retrospective Real-world Study of Abemaciclib in HR+ Breast Cancer

Not yet recruiting

Conditions: Breast Cancer
Breast Diseases
Neoplasms

Interventions: Drug: Letrozole or Anastrozole
Drug: Abemaciclib and Fulvestrant
Drug: Fulvestrant
Drug: Abemaciclib and Letrozole/Anastrozole

First Posted Date: 2024-04-02

Last Posted Date: 2024-05-10

Lead Sponsor: The Affiliated Hospital of Qingdao University

Target Recruit Count: 200

Registration Number: NCT06341283

Locations: 🇨🇳
Clinical Research Center, Qingdao, Shandong, China

Comparative Pharmacokinetic Study of Aprepitant Injection in Humans

Phase 1

Not yet recruiting

Conditions: Healthy

Interventions: Drug: Test (T) Aprepitant injection
Drug: Reference (R) Aprepitant injection

First Posted Date: 2024-01-26

Last Posted Date: 2024-01-26

Lead Sponsor: The Affiliated Hospital of Qingdao University

Target Recruit Count: 24

Registration Number: NCT06226506

Bioequivalence Study of Entacapone,Levodopa and Carbidopa Tablets in the Postprandial State in Healthy Chinese Subjects

Phase 1

Not yet recruiting

Conditions: Healthy

Interventions: Drug: Test (T) Entacapone,Levodopa and Carbidopa Tablets (II)
Drug: Reference (R) Entacapone,Levodopa and Carbidopa Tablets (II)

First Posted Date: 2023-12-22

Last Posted Date: 2023-12-22

Lead Sponsor: The Affiliated Hospital of Qingdao University

Target Recruit Count: 36

Registration Number: NCT06180720

The Application of Balanced Propofol Sedation in Fiberoptic Bronchoscopy

Completed

Conditions: Bronchoscopy

Interventions: Drug: Midazolam and sufentanil
Drug: Midazolam, sufentanil and propofol
Drug: Remazolam and sufentanil.
Drug: Remazolam, sufentanil and propofol

First Posted Date: 2023-11-03

Last Posted Date: 2024-01-31

Lead Sponsor: The Affiliated Hospital of Qingdao University

Target Recruit Count: 424

Registration Number: NCT06116955

Locations: 🇨🇳
Affiliated Hospital of Qingdao University, Shandong, Qingdao, China

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy